FDA Drug · D-0563-2025

Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

Class II · Ongoing

Lack of Processing Controls.

Advertisement
Advertisement
Affected lots / codes — check yours against thisAll Lots within expiry.
Recalling firm
AEQUITA PHARMACY, Kirkland, WA
Classification
Class II (temporary or reversible harm possible)
Status
Ongoing
Quantity
190 vials
Distribution
MA
Recall initiated
July 18, 2025
Classified
August 1, 2025
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0563-2025%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →